14 results
8-K
EX-10.1
IPIX
Innovation Pharmaceuticals Inc.
15 Jun 22
Entry into a Material Definitive Agreement
4:00pm
, financial, marketing and business data, pricing and cost information, business and marketing plans and customer and supplier lists and information
POS AM
0022z 7t4
17 Oct 19
Prospectus update (post-effective amendment)
5:23pm
8-K
EX-10.1
kb1elq l3b8
22 Jul 19
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.1
kcdwryg2y7 eje
24 Oct 14
Cellceutix Announces Positive Top-Line Data From Phase 2b ABSSSI Trial; Single-Dose Brilacidin Comparable to 7-Days of Daptomycin
12:00am
- Prev
- 1
- Next